{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T06:01:23Z","timestamp":1766901683907,"version":"3.48.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"University of Medicine and Pharmacy at Ho Chi Minh City"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10951-z","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T07:50:43Z","timestamp":1755935443000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Spectrum of BTK gene mutations in Vietnamese patients with X-linked agammaglobulinemia"],"prefix":"10.1007","volume":"52","author":[{"given":"Phan Thi","family":"Xinh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Quoc","family":"Chuong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoang Phan","family":"Thanh Hien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huynh","family":"Nghia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phan Nguyen","family":"Lien Anh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoang","family":"Le Phuc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen Hoang","family":"Mai Anh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen Dinh","family":"Van","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoang Anh","family":"Vu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,23]]},"reference":[{"key":"10951_CR1","unstructured":"Lackey AE, Ahmad F (2025) X-Linked Agammaglobulinemia. StatPearls Publishing. Accessed Jan 2025"},{"key":"10951_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/S12016-021-08870-5","volume":"63","author":"M Cardenas-Morales","year":"2022","unstructured":"Cardenas-Morales M, Hernandez-Trujillo VP (2022) Agammaglobulinemia: from X-linked to autosomal forms of disease. Clin Rev Allergy Immunol 63:22\u201335. https:\/\/doi.org\/10.1007\/S12016-021-08870-5","journal-title":"Clin Rev Allergy Immunol"},{"key":"10951_CR3","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1016\/j.molimm.2009.03.012","volume":"46","author":"B T\u00f3th","year":"2009","unstructured":"T\u00f3th B, Volokha A, Mihas A et al (2009) Genetic and demographic features of X-linked agammaglobulinemia in Eastern and central europe: a cohort study. Mol Immunol 46:2140\u20132146. https:\/\/doi.org\/10.1016\/j.molimm.2009.03.012","journal-title":"Mol Immunol"},{"key":"10951_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ph16030400","author":"A Najmi","year":"2023","unstructured":"Najmi A, Thangavel N, Mohanan AT et al (2023) Structural complementarity of bruton\u2019s tyrosine kinase and its inhibitors for implication in B-cell malignancies and autoimmune diseases. Pharmaceuticals. https:\/\/doi.org\/10.3390\/ph16030400","journal-title":"Pharmaceuticals"},{"key":"10951_CR5","doi-asserted-by":"publisher","DOI":"10.7554\/ELIFE.82676","author":"LM Nocka","year":"2023","unstructured":"Nocka LM, Eisen TJ, Iavarone AT et al (2023) Stimulation of the catalytic activity of the tyrosine kinase Btk by the adaptor protein Grb2. Elife. https:\/\/doi.org\/10.7554\/ELIFE.82676","journal-title":"Elife"},{"key":"10951_CR6","doi-asserted-by":"publisher","unstructured":"Kueffer LE, Joseph RE, Andreotti AH (2021) Reining in BTK: interdomain interactions and their importance in the regulatory control of BTK. Front Cell Dev Biol 9. https:\/\/doi.org\/10.3389\/FCELL.2021.655489\/PDF","DOI":"10.3389\/FCELL.2021.655489\/PDF"},{"key":"10951_CR7","doi-asserted-by":"publisher","unstructured":"Schaafsma GCP, V\u00e4liaho J, Wang Q et al (2023) BTKbase, Bruton tyrosine kinase variant database in X-Linked agammaglobulinemia: looking back and ahead. https:\/\/doi.org\/10.1155\/2023\/5797541. Hum Mutat 2023:","DOI":"10.1155\/2023\/5797541"},{"key":"10951_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/82_2015_478","volume":"393","author":"OBJ Corneth","year":"2015","unstructured":"Corneth OBJ, Klein Wolterink RGJ, Hendriks RW (2015) BTK signaling in B cell differentiation and autoimmunity. Curr Top Microbiol Immunol 393:67\u2013105. https:\/\/doi.org\/10.1007\/82_2015_478","journal-title":"Curr Top Microbiol Immunol"},{"issue":"200001","key":"10951_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/(SICI)1098-1004","volume":"15","author":"JT Den Dunnen","year":"2000","unstructured":"Den Dunnen JT, Antonarakis SE (2000) Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion. Hum Mutat 15(200001):7\u201312. https:\/\/doi.org\/10.1002\/(SICI)1098-1004. ::AID-HUMU4>3.0.CO;2-N,","journal-title":"Hum Mutat"},{"key":"10951_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/S12881-020-01063-5","volume":"21","author":"S Gao","year":"2020","unstructured":"Gao S, Hu S, Duan H et al (2020) Clinical characteristics and prenatal diagnosis for 22 families in Henan Province of China with X-linked agammaglobulinemia (XLA) related to bruton\u2019s tyrosine kinase (BTK) gene mutations. BMC Med Genet 21:131. https:\/\/doi.org\/10.1186\/S12881-020-01063-5","journal-title":"BMC Med Genet"},{"key":"10951_CR11","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/HUMU.9219","volume":"23","author":"M Fiorini","year":"2004","unstructured":"Fiorini M, Franceschini R, Soresina A et al (2004) BTK: 22 novel and 25 recurrent mutations in European patients with X-linked agammaglobulinemia. Hum Mutat 23:286. https:\/\/doi.org\/10.1002\/HUMU.9219","journal-title":"Hum Mutat"},{"issue":"4","key":"10951_CR12","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/HUMU.1200","volume":"18","author":"Y Wang","year":"2001","unstructured":"Wang Y, Kanegane H, Sanal O et al (2001) Bruton tyrosine kinase gene mutations in Turkish patients with presumed X-linked agammaglobulinemia. Hum Mutat 18:356. https:\/\/doi.org\/10.1002\/HUMU.1200","journal-title":"Hum Mutat"},{"key":"10951_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.18502\/IJAAI.V19I3.3458","volume":"19","author":"Z Alizadeh","year":"2020","unstructured":"Alizadeh Z, Dashti P, Mazinani M et al (2020) Clinical and genetic study of X-linked agammaglobulinemia patients (The benefit of early Diagnosis). Iran J Allergy Asthma Immunol 19:305\u2013309. https:\/\/doi.org\/10.18502\/IJAAI.V19I3.3458","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"10951_CR14","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1023\/A:1019982206951","volume":"22","author":"JG Noordzij","year":"2002","unstructured":"Noordzij JG, De Bruin-Versteeg S, Hartwig NG et al (2002) XLA patients with BTK splice-site mutations produce low levels of wild-type BTK transcripts. J Clin Immunol 22:306\u2013318. https:\/\/doi.org\/10.1023\/A:1019982206951","journal-title":"J Clin Immunol"},{"key":"10951_CR15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/S10875-016-0251-Z","volume":"36","author":"Z Aadam","year":"2016","unstructured":"Aadam Z, Kechout N, Barakat A et al (2016) X-linked agammagobulinemia in a large series of North African patients: frequency, clinical features and novel BTK mutations. J Clin Immunol 36:187\u2013194. https:\/\/doi.org\/10.1007\/S10875-016-0251-Z","journal-title":"J Clin Immunol"},{"key":"10951_CR16","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/J.0105-2896.2005.00233.X","volume":"203","author":"ME Conley","year":"2005","unstructured":"Conley ME, Broides A, Hernandez-Trujillo V et al (2005) Genetic analysis of patients with defects in early B-cell development. Immunol Rev 203:216\u2013234. https:\/\/doi.org\/10.1111\/J.0105-2896.2005.00233.X","journal-title":"Immunol Rev"},{"key":"10951_CR17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1182\/BLOOD.V88.2.561.BLOODJOURNAL882561","volume":"88","author":"S Hashimoto","year":"1996","unstructured":"Hashimoto S, Tsukada S, Matsushita M et al (1996) Identification of bruton\u2019s tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan. Blood 88:561\u2013573. https:\/\/doi.org\/10.1182\/BLOOD.V88.2.561.BLOODJOURNAL882561","journal-title":"Blood"},{"key":"10951_CR18","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1542\/peds.101.2.276","volume":"101","author":"E Holinski-Feder","year":"1998","unstructured":"Holinski-Feder E, Weiss M, Brandau O et al (1998) Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course. Pediatrics 101:276\u2013284. https:\/\/doi.org\/10.1542\/peds.101.2.276","journal-title":"Pediatrics"},{"issue":"6","key":"10951_CR19","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1136\/jmg.34.6.484","volume":"34","author":"RA Brooimans","year":"1997","unstructured":"Brooimans RA, Van Den Berg AJAM, Rijkers GT et al (1997) Identification of novel bruton\u2019s tyrosine kinase mutations in 10 unrelated subjects with X linked agammaglobulinaemia. J Med Genet 34(6):484\u2013488. https:\/\/doi.org\/10.1136\/jmg.34.6.484","journal-title":"J Med Genet"},{"key":"10951_CR20","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/J.MOLIMM.2007.07.022","volume":"45","author":"G Lopez-Herrera","year":"2008","unstructured":"Lopez-Herrera G, Berron-Ruiz L, Mogica-Martinez D et al (2008) Characterization of bruton\u2019s tyrosine kinase mutations in Mexican patients with X-linked agammaglobulinemia. Mol Immunol 45:1094\u20131098. https:\/\/doi.org\/10.1016\/J.MOLIMM.2007.07.022","journal-title":"Mol Immunol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10951-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10951-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10951-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T04:28:02Z","timestamp":1766896082000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10951-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,23]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10951"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10951-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2025,8,23]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no conflict of interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the Ethics Committee of the University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam (approval number 2658\/HDDD-DHYD). Written informed consent was obtained from the parents or legal guardians of all minors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"841"}}